Blood Clots

3 Tools for Better Management of Non-Valvular Atrial Fibrillation

By Jane Nelson Worel RN, MS, ANP-BC, FAHA (Clinical Education, Preventive Cardiovascular Nurses Association)

Helping patients with Non-Valvular Atrial Fibrillation (NVAF) involves implementing guidelines-based strategies to effectively balance the reduced risk of deadly or debilitating strokes with the risk of bleeding—along with factors such as patient age and overall health. To help clinicians navigate the challenges faced by patients with Atrial Fibrillation (AFib)—the most common arrhythmia seen in clinical practice—the Preventive Cardiovascular Nurses Association (PCNA) has developed a trio of educational and reference tools for providers that will increase knowledge and directly impact clinical practice.

Read More

Blood Clots, Patient Safety, Physician-Patient Relationship

Virtual Clinic to Help Atrial Fibrillation (Afib) Patients During COVID-19 Crisis

The Physician-Patient Alliance for Health and Safety (PPAHS) today announced the launch of a new, free virtual clinic and website, Virtual Patient Care, in response to the COVID-19 crisis, to meet the pressing needs of patients with atrial fibrillation (Afib), who are at the highest level of risk from stroke, and to help Afib patients cope with the difficulties imposed by COVID-19. 

“Under current COVID-19 conditions, patients face the burdens of social distancing and increased difficulty in reaching clinicians busy with emergencies. Telehealth has proven essential in addressing patients’ pressing health needs and ensuring good patient-to-clinician dialogue,” said Michael Wong, JD, Founder and Executive Director of the Physician-Patient Alliance for Health & Safety. “With today’s launch of Virtual Patient Care and the CV Virtual Clinic, vital telehealth benefits are now also extended to Afib patients in need.”

Read More

Must Reads

3 New Clinical Guidelines To Take Note of

Editor’s note: In this week’s must reads, we look at 3 new clinical guidelines and consider their impact on patient care.

Guideline for the Management of Patients With Atrial Fibrillation

The newly released “Guideline for the Management of Patients With Atrial Fibrillation” is a game changer for the use of anticoagulants. In a report by the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, in Collaboration With the Society of Thoracic Surgeons, newer anticoagulants, known as non-vitamin K oral anticoagulants (NOACs), are recommended over the traditional warfarin to prevent stroke in people with atrial fibrillation (AFib).

Read More

Blood Clots

Early Detection of AFib: Empowering Patients

PPAHS is proud to support and participate in WomenHeart’s National AFib Month Screening Campaign. PPAHS asks clinicians to please screen for AFib.

By WomenHeart (WomenHeart: The National Coalition for Women with Heart Disease, is a nonprofit, 501(c)(3) patient advocacy organization with thousands of members nationwide, including women heart patients and their families, health care providers, advocates and consumers committed to helping women live longer, healthier lives. WomenHeart supports, educates and advocates on behalf of the nearly 48 million American women living with or at risk of heart disease.)

Approximately 1.5 million American women live with atrial fibrillation (AFib), which is an irregular heartbeat. One of the most effective means of detection of AFib is through “opportunistic screenings” with primary care providers, these screenings identify more people with AFib than arranged screenings.

Read More

Blood Clots

Atrial Fibrillation: Early Detection and Risk Reduction

In this guest post by Drs. Nidhi Madan and Annabelle Volgman discuss why early detection of AFib can lead to a significant reduction of risk.

Nidhi Madan, MD, MPH; Annabelle S. Volgman, MD, FACC, FAHA 

Atrial fibrillation (AFib) is the most common cardiac arrhythmia, with its prevalence projected to increase from 5.2 million in 2010 to 12.1 million cases in 2030 in the United States.1 AFib confers a higher risk of stroke, heart failure, cognitive decline and mortality.2,3 Early identification of AFib is imperative to reduce morbidity and mortality. Several factors cause structural and electrical remodeling of the atria resulting in AFIB. Established non-modifiable risk factors for AFib include advanced age and male sex. Female sex is a risk factor for strokes for patients with AFib. Other modifiable risk factors include smoking, alcohol use, obesity, diabetes, hypertension, sleep apnea, myocardial infarction, valve disease and heart failure.

Read More

Blood Clots

Participate in WomenHeart’s National AFib Month Screening Campaign

PPAHS is proud to support and participate in WomenHeart’s National AFib Month Screening Campaign. PPAHS asks clinicians to please screen for AFib.

By WomenHeart (WomenHeart: The National Coalition for Women with Heart Disease, is a nonprofit, 501(c)(3) patient advocacy organization with thousands of members nationwide, including women heart patients and their families, health care providers, advocates and consumers committed to helping women live longer, healthier lives. WomenHeart supports, educates and advocates on behalf of the nearly 48 million American women living with or at risk of heart disease.)

Studies show that early detection of AFib can reduce an individual’s risk of stroke by as much as 60 percent. WomenHeart: The National Coalition for Women with Heart Disease, is launching the “Nationwide AFib Month Opportunistic Screening Initiative.”

Read More